Challenges of Legal Marijuana Consumption in Vermont and New York

Dec.07.2022
Challenges of Legal Marijuana Consumption in Vermont and New York
Vermont legalized personal marijuana use for adults, but public consumption is prohibited, making it one of the least friendly states.

In 2018, the state of Vermont passed bill number 86 which legalized the cultivation, possession and consumption of small amounts of marijuana for adults aged 21 and over in their homes. This was two years prior to legislators passing bill number 164 in 2020 which legalized commercial marijuana.


However, it remains one of the least friendly states towards legal consumption.


Who will be most affected by Vermont's cannabis consumption law, why has New York gained recognition for its new consumption law, and what can Vermont's lawmakers do to make the state more cannabis-friendly for its residents and tourists?


The states of Vermont and New York.


In Vermont, it is illegal to consume marijuana in public places. Renters, including those using short-term rentals, hotels, and Airbnb, must obtain permission from the landlord or property owner before smoking or growing marijuana in their homes, even if they are registered medical marijuana patients or caregivers.


The consumption of marijuana in Vermont is defined as any form of use, such as smoking, vaping, or consuming edibles, all of which are prohibited in public places and subject to civil penalties.


In the state of New York, it is legal to consume marijuana in any public place where smoking is allowed. Tenants and non-property owners are also allowed to consume and cultivate medical marijuana in their homes unless the landlord explicitly prohibits it.


Although New York has not yet legalized adult recreational marijuana cultivation at home, it does allow for medical cultivation and has taken impressive measures to protect the rights of medical patients and caregivers. For example, if a landlord prohibits smoking, patients are allowed to consume marijuana in other forms.


Lawmakers in New York state have placed the responsibility for compliance with their marijuana consumption law on the landlords, while lawmakers in Vermont have placed the responsibility on the tenants.


Who is protected by Vermont state law?


The state of Vermont's law limits marijuana consumption to the private residences of homeowners and tenants who have obtained explicit permission from their landlords. Therefore, homeowners are the main group protected by the law, and looking at who owns the property will tell us who is legally allowed to consume.


According to the latest US Census data, homeownership rates in Vermont by race/ethnicity are as follows: Black - 21.1%, Hispanic - 38.6%, American Indian/Alaska Native - 45.6%, Asian - 50.5%, and White - 72.6%.


Compared to other states, Vermont ranks fifth in terms of the disparity in homeownership rates for Black households nationwide. This data reveals that Black, Indigenous, and people of color communities in Vermont are least likely to own homes, and therefore have the least legal protection when it comes to consuming cannabis.


Apart from the low homeownership rate among BIPOC communities in Vermont, a report by the ACLU has found that despite the legalization of cannabis in 2018, black individuals in Vermont are arrested more frequently than their white counterparts for cannabis-related offenses, even though usage rates are similar.


Providing legal marijuana consumption spaces for all Vermont residents is an urgent public safety issue.


Tourists and visitors to Vermont are also affected by the law, as public consumption is prohibited and short-term rentals, hotels, and Airbnb require clear permits under the law. The tourism industry, which annually welcomes more than 13 million visitors, is an important sector in Vermont. If adults visiting Vermont can responsibly enjoy tobacco legally, then they should also be able to enjoy marijuana in the same way.


How can Vermont lawmakers improve the law?


Due to the recent midterm elections, the Democratic and Progressive Parties of Vermont now hold a majority in the state legislature and have the power to veto the governor's decisions.


We are calling on Vermont legislators to reexamine the marijuana consumption law during the 2023 legislative session and legalize public marijuana consumption in any location where tobacco is allowed, such as New York State. We also propose allowing non-homeowners, such as renters, to consume, possess, and grow marijuana unless explicitly prohibited by their landlord or property owner. Additionally, we suggest creating a new license category to allow consumption establishments and events, providing some form of direct-to-consumer access for growers and manufacturers.


The communities in Vermont have historically been targets of prohibition, and even with legalization, they continue to be targeted by law enforcement, not protected under the state's marijuana consumption laws. This is harmful public policy. Additionally, adult visitors to Vermont find themselves in a contradictory position, legally able to purchase marijuana and marijuana products but with no legal place to consume them.


New York lawmakers have begun securing the right for their residents and visitors to consume marijuana. Lawmakers in Vermont should follow suit by 2023, while also addressing the numerous flaws in the adult-use market, rather than replacing other jobs.


2FIRSTS will continue to track and report on this issue, with updates available on the '2FIRSTS APP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09